177 related articles for article (PubMed ID: 3224445)
1. Immunological properties of the human Goodpasture target antigen.
Weber M; Meyer zum Büschenfelde KH; Köhler H
Clin Exp Immunol; 1988 Nov; 74(2):289-94. PubMed ID: 3224445
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
Thorner PS; Baumal R; Eddy A; Marrano P
Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812
[TBL] [Abstract][Full Text] [Related]
3. Identification of Goodpasture target antigens in basement membranes of human glomeruli, lung, and placenta.
Weber M; Köhler H; Manns M; Baum HP; Meyer zum Büschenfelde KH
Clin Exp Immunol; 1987 Feb; 67(2):262-9. PubMed ID: 3608225
[TBL] [Abstract][Full Text] [Related]
4. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis.
Derry CJ; Pickering M; Baker C; Pusey CD
Exp Nephrol; 1994; 2(4):249-56. PubMed ID: 7520821
[TBL] [Abstract][Full Text] [Related]
6. Development and application of an ELISA for Goodpasture's disease based on sheep alpha 3(IV)NC1 domains.
Katbamna I; Turner N; Ross CN; Pusey CD
J Clin Lab Immunol; 1995; 47(1):11-24. PubMed ID: 8735432
[TBL] [Abstract][Full Text] [Related]
7. Different immunologic properties of the globular NC1 domain of collagen type IV isolated from various human basement membranes.
Weber M; Pullig O
Eur J Clin Invest; 1992 Feb; 22(2):138-46. PubMed ID: 1374033
[TBL] [Abstract][Full Text] [Related]
8. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
Cui Z; Zhao MH
Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
[TBL] [Abstract][Full Text] [Related]
9. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
10. Identification of Goodpasture antigens in human alveolar basement membrane.
Yoshioka K; Iseki T; Okada M; Morimoto Y; Eryu N; Maki S
Clin Exp Immunol; 1988 Dec; 74(3):419-24. PubMed ID: 2466590
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tubular basement membrane antigens in human kidney.
Yoshioka K; Morimoto Y; Iseki T; Maki S
J Immunol; 1986 Mar; 136(5):1654-60. PubMed ID: 3005398
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
13. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
[TBL] [Abstract][Full Text] [Related]
14. Alveolar basement membrane: molecular properties of the noncollagenous domain (hexamer) of collagen IV and its reactivity with Goodpasture autoantibodies.
Gunwar S; Bejarano PA; Kalluri R; Langeveld JP; Wisdom BJ; Noelken ME; Hudson BG
Am J Respir Cell Mol Biol; 1991 Aug; 5(2):107-12. PubMed ID: 1892641
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting.
Derry CJ; Pusey CD
Nephrol Dial Transplant; 1994; 9(4):355-61. PubMed ID: 8084446
[TBL] [Abstract][Full Text] [Related]
16. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Goodpasture antigens within various human basement membranes.
Weber M; Pullig O; Köhler H
Nephrol Dial Transplant; 1990; 5(2):87-93. PubMed ID: 2113218
[TBL] [Abstract][Full Text] [Related]
18. Characterization of type IV collagen NC1 monomers and Goodpasture antigen in human renal basement membranes.
Butkowski RJ; Shen GQ; Wieslander J; Michael AF; Fish AJ
J Lab Clin Med; 1990 Mar; 115(3):365-73. PubMed ID: 1690255
[TBL] [Abstract][Full Text] [Related]
19. Antibody specificity of human glomerular basement membrane type IV collagen NC1 subunits. Species variation in subunit composition.
Kleppel MM; Michael AF; Fish AJ
J Biol Chem; 1986 Dec; 261(35):16547-52. PubMed ID: 3782134
[TBL] [Abstract][Full Text] [Related]
20. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
